存活率损失与指导方针为退行性 mitrale 排泄手术的指导方针相关
David Vancraeynest1, Anne-Catherine Pouleur1, Christophe de Meester1
1Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc, and IREC/CARD UCLouvain, Av Hippocrate 10/2806, B-1200 Brussels, Belgium.
European heart journal. Cardiovascular Imaging
|July 12, 2024
概括
在退行性 mitrale regurgitation (DMR) 患者中等待基于指南的手术触发器与减少生存时间有关. 建议早期进行手术,以改善DMR患者的治疗结果.
科学领域:
- 心血管外科心血管外科
- 心脏外科手术 心脏外科手术
- 中心门疾病的疾病.
背景情况:
- 目前针对重症退行性额回 (DMR) 的操作指南是基于ACC/AHA或ESC/EACTS的建议.
- 关于最佳手术时间及其对DMR手术后长期生存的影响存在不确定性.
研究的目的:
- 调查是否遵守基于指南的DMR手术指示与晚期术后生存损失有关.
- 评估不同手术触发器类对患者结果的影响.
主要方法:
- 分析了2833名经过DMR外科纠正的患者,这些患者来自Mitral Regurgitation国际数据库注册表.
- 根据手术指示对患者的分层:I类,孤立的IIa类,或没有触发.
- 使用受限平均生存时间 (RMST) 分析和临床差异匹配后的危险比率对术后生存率的比较.
主要成果:
- 与IIa类或没有触发器相比,为I类触发器进行手术的患者的长期存活率明显较低 (分别为71.4%和84.3%和88.9%在10年).
- 一类触发因素与过度死亡率相关 (P < 0.001),多个I类标准增加死亡风险 (HR: 1.53).
- 单独的IIa类触发因素也增加了死亡风险 (HR:1.46,P = 0.05),单独的肺高血压或心房动与生存率下降有关.
结论:
- 在I类或单独的IIa类触发物显现之前,推迟对退行性额回的手术与显著的术后生存损失有关.
- 这些发现支持对严重DMR患者的早期手术干预策略,以改善长期存活率.
相关概念视频
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
948
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
948
Mitral Regurgitation III: Medical Management
691
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Mitral Regurgitation IV: Nursing Management
608
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
608
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management
539
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539


